February 2004 Newsletter

Table of Contents:

• President's Message
• Plan Now for the ICCVA 2004 Meeting to be held in Tokyo
• Literature Reviews
  • Usefulness of statin drugs in protecting against atrial fibrillation in patients with coronary artery disease
  • Morbidity and Mortality of a Failed Attempt at Mitral Valve Repair Converted to Replacement at the Same Operation
• Drug & Innovation Review
  • Levosimendan, a new Ca²⁺-sensitizing inotropic agent
• PRO/CON
  • Pro: Cardiac surgery without use of CPB does not require 'full' dose heparinization - Bruce D. Spiess, MD, FAHA
  • Con: Low Dose Heparin - Kenichi A. Tanaka, MD; Jerrold H. Levy, MD

Archived Newsletter Articles

© Society of Cardiovascular Anesthesiologists
Questions or comments? Please send email to webmaster@scahq.org